Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
Abstract INTRODUCTION Brain‐derived tau (BD‐tau) measures tau specifically from brain‐derived sources and can differentiate Alzheimer's disease (AD) from other diseases. This study investigated BD‐tau as a potential biomarker of treatment effect. METHODS BD‐tau and phosphorylated tau‐217 (p‐tau...
Saved in:
| Main Authors: | Cassandra Marotta, Fernando Gonzalez‐Ortiz, Michael Turton, Henrik Zetterberg, Peter Harrison, Christopher M. Hovens, Benjamin Sinclair, Terence J. O'Brien, Kaj Blennow, Lucy Vivash |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/dad2.70123 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
by: Binita Rajbanshi, et al.
Published: (2025-01-01) -
Looking into Abnormal Co-Expressions of Tau and TDP-43 in the Realm of Mixed Dementia Types: A Double-Punch Scenario
by: Hossam Youssef, et al.
Published: (2025-07-01) -
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
by: Juan Lantero‐Rodriguez, et al.
Published: (2021-11-01) -
Tau as a fluid biomarker of concussion and neurodegeneration
by: Iftakher Hossain, et al.
Published: (2022-06-01) -
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)